Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

44.1K
Overview
44.1K
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

204
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
204

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Therapeutic inhibition of USP7 promotes antitumor immune responses.

Journal for immunotherapy of cancer·2025
Same author

Chitinase-1 inhibition attenuates metabolic dysregulation and restores homeostasis in MASH animal models.

Frontiers in immunology·2025
Same author

Novel orally bioavailable piperidine derivatives as extracellular arginase inhibitors developed by a ring expansion.

European journal of medicinal chemistry·2023
Same author

The Anti-Inflammatory Effect of Acidic Mammalian Chitinase Inhibitor OAT-177 in DSS-Induced Mouse Model of Colitis.

International journal of molecular sciences·2022
Same author

Potent but transient immunosuppression of T-cells is a general feature of CD71<sup>+</sup> erythroid cells.

Communications biology·2021
Same author

A Novel Oral Arginase 1/2 Inhibitor Enhances the Antitumor Effect of PD-1 Inhibition in Murine Experimental Gliomas by Altering the Immunosuppressive Environment.

Frontiers in oncology·2021

Related Experiment Video

Updated: Apr 30, 2026

Obtaining Highly Purified Toxoplasma gondii Oocysts by a Discontinuous Cesium Chloride Gradient
11:17

Obtaining Highly Purified Toxoplasma gondii Oocysts by a Discontinuous Cesium Chloride Gradient

Published on: November 3, 2009

14.9K

Veterinary vaccines against toxoplasmosis.

Elżbieta Hiszczyńska-Sawicka1, Justyna M Gatkowska2, Marcin M Grzybowski2

  • 1AgResearch,Private Bag 4749, Christchurch,New Zealand.

Parasitology
|May 9, 2014
PubMed
Summary

Developing vaccines against Toxoplasma gondii is crucial for preventing economic losses and human health issues. Promising results from conventional vaccine trials in farm animals offer a hopeful starting point for future toxoplasmosis prevention strategies.

More Related Videos

Forward Genetics Screens Using Macrophages to Identify Toxoplasma gondii Genes Important for Resistance to IFN-&#947;-Dependent Cell Autonomous Immunity
11:21

Forward Genetics Screens Using Macrophages to Identify Toxoplasma gondii Genes Important for Resistance to IFN-γ-Dependent Cell Autonomous Immunity

Published on: March 12, 2015

9.6K
3-D Imaging and Analysis of Neurons Infected In Vivo with Toxoplasma gondii
06:33

3-D Imaging and Analysis of Neurons Infected In Vivo with Toxoplasma gondii

Published on: December 9, 2014

11.1K

Related Experiment Videos

Last Updated: Apr 30, 2026

Obtaining Highly Purified Toxoplasma gondii Oocysts by a Discontinuous Cesium Chloride Gradient
11:17

Obtaining Highly Purified Toxoplasma gondii Oocysts by a Discontinuous Cesium Chloride Gradient

Published on: November 3, 2009

14.9K
Forward Genetics Screens Using Macrophages to Identify Toxoplasma gondii Genes Important for Resistance to IFN-&#947;-Dependent Cell Autonomous Immunity
11:21

Forward Genetics Screens Using Macrophages to Identify Toxoplasma gondii Genes Important for Resistance to IFN-γ-Dependent Cell Autonomous Immunity

Published on: March 12, 2015

9.6K
3-D Imaging and Analysis of Neurons Infected In Vivo with Toxoplasma gondii
06:33

3-D Imaging and Analysis of Neurons Infected In Vivo with Toxoplasma gondii

Published on: December 9, 2014

11.1K

Area of Science:

  • Veterinary Parasitology
  • Immunology
  • One Health

Background:

  • Toxoplasma gondii is a widespread protozoan parasite causing significant economic losses in livestock (e.g., ovine abortions) and human health concerns (e.g., congenital and neurotoxoplasmosis).
  • Current prevention strategies are limited, with only one vaccine (Toxovax for sheep) available, highlighting a critical gap in protecting both animal and human health.
  • Farm animals are key reservoirs and transmission vectors for T. gondii, making them essential targets for intervention strategies.

Purpose of the Study:

  • To review the current status and challenges in developing vaccines against Toxoplasma gondii specifically for farm animals.
  • To assess the progress and potential of vaccine development for preventing toxoplasmosis in livestock relevant to food production and farm environments.
  • To identify promising avenues for future research and development of effective toxoplasmosis vaccines.

Main Methods:

  • Review of existing literature on Toxoplasma gondii vaccine development trials, focusing on farm animals.
  • Comparative analysis of vaccine research in laboratory animals versus farm animals.
  • Evaluation of conventional vaccine approaches and their outcomes in preventing toxoplasmosis.

Main Results:

  • Vaccine development for farm animals against T. gondii has been limited compared to laboratory animal research.
  • Despite fewer trials, existing studies using conventional vaccines have yielded promising results.
  • The data suggests that current research provides a solid foundation for developing effective toxoplasmosis vaccines for livestock.

Conclusions:

  • There is a pressing need for effective vaccines against Toxoplasma gondii in farm animals to mitigate economic and public health impacts.
  • Promising results from ongoing conventional vaccine trials indicate a viable path forward for T. gondii prevention in livestock.
  • Further research and development are warranted to translate these promising findings into widely available and effective vaccines for toxoplasmosis control.